Diosmin with hesperidin

View my plan →

The short answer

Micronized flavonoid products may improve selected chronic venous or hemorrhoid symptoms.

Evidence and scope: Conditional or population-specific
This status does not grade the ingredient for every goal, outcome, or person.
Important limitation: Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding: Key concern: Anticoagulants, bleeding disorders, pregnancy, kidney/liver disease, and surgery require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective

Venous symptoms500–1,000 mg/day micronized flavonoid fraction in trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Take with meals and match the studied ratio.

Do not combine casually

Anticoagulants, bleeding disorders, pregnancy, kidney/liver disease, and surgery require review.

Dose and use source ↗

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger

7unique primary studies represented

1,692unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2018

Supports a specific usePMID 29385792

Micronized purified flavonoid fraction for chronic venous disease

The tested micronized fraction improved multiple venous symptoms, ankle circumference, and quality of life versus placebo. Results apply to the characterized formulation and symptomatic outcomes; they do not establish prevention of thrombosis, ulceration, or long-term disease progression.

Published: 2018n=1,692 participants7 primary studies represented

Study design and methods

Design: Systematic review and meta-analysis of 7 randomized, double-blind, placebo-controlled trials
Population: 1,692 people with chronic venous disease
Intervention: A branded micronized purified flavonoid fraction containing mostly diosmin with accompanying flavonoids versus placebo
Outcome: Leg pain, heaviness, swelling, cramps, other symptoms, edema, skin signs, and quality of life

Funding or conflict note: The evidence concerns the characterized branded micronized fraction and should not be generalized to unverified diosmin-hesperidin products.

Open research record ↗

Unscreened discovery appendix—not evidence22 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

Official evidence overviewPubMed bounded human-evidence search Live PubMed discovery searchNational Library of Medicine

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.